The marijuana industry has attracted many investors. Even mainstream corporations are trying to get in on the action. Read More
CRON
Filter
Despite the overall bear market and macroeconomic headwinds, mergers and acquisitions continue apace in the pot sector. Read More
Merger and acquisition activity has reached a fever pitch in the marijuana industry, as consolidation gathers speed amid a cannabis equities rally. Read More
Cannabis dispensary chain MedMen seeks to become the "Whole Foods of Pot Shops." Will the company succeed or is it stretched too thin? Read More
Cannabis player Cronos Group is flush with cash, after tobacco giant Altria bought a huge stake in the firm. Does Cronos deserve the hype? Read More
This clinical stage marijuana biotech is garnering eager investor interest. Is the company poised for greatness or disappointment? Read More
"Sin" stock Philip Morris boasts heavenly dividends. But now, this Big Tobacco stalwart is transitioning to reduced-risk products. Can it succeed? Read More
With FDA Chief Scott Gottlieb's departure, we're already seeing big price swings in stocks that may be affected by a change in FDA policy towards tobacco and health care companies. Read More